Healthcare

Imugene Receives Second Ethics Approval to Commence PD1-Vaxx Phase 1...

July 17, 2020 03:04 PM AEST | By Team Kalkine Media

Clinical stage immuno-oncology firm based in Australia, Imugene Limited (ASX:IMU) has received a second human research ethics approval from the Sydney...

Emerging Healthcare Space, a Treasure-trove with a Secured Future: L...

July 15, 2020 04:26 PM AEST | By Team Kalkine Media

Summary With growing cases of chronic ailments, increasing elderly population, and the rising demand for complex surgical procedures, the medical t...

Did We Miss Anything On ASX-listed Aged-care Facility Providers: EHE...

July 13, 2020 07:49 PM AEST | By Team Kalkine Media

An aged care system helps older individuals to live independently in their homes and provides support and accommodation when this is no longer possibl...

Medical Device Stocks and Portfolio Diversification - Lens on high-p...

July 12, 2020 12:30 AM AEST | By Team Kalkine Media

Summary Australian medical device industry is well-established with an internationally-renowned capability to modernise and develop world-class med...

Mesoblast was the top gainer on the ASX today; Let’s find out why

July 06, 2020 09:08 PM AEST | By Kunal Sawhney

COVID-19 turmoil is a public health crunch, with staggering fatalities and human suffering beyond words. This unprecedented crisis is being deeme...

ASX-listed Dental Stocks: Is there any relief coming in? PSQ, ONT, S...

July 01, 2020 02:50 PM AEST | By Team Kalkine Media

Due to the rising number of coronavirus infections, many businesses were shut down amid COVID-19-induced restrictions. At the same time, some business...

ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HR...

June 23, 2020 03:35 PM AEST | By Team Kalkine Media

The healthcare sector across the world is struggling with the myriad challenges thrown by the COVID-19 pandemic, and virtual healthcare is fast becomi...

ASX biotech companies creating a pandemic-free buzz!

June 21, 2020 12:00 AM AEST | By Team Kalkine Media

As on 19 June 2020, the “pneumonia-like” illness has taken 456,432 lives with 8,538,928 confirmed cases recorded worldwide.  And with...

Are Investors Buying these Healthcare Stocks: Starpharma, Sigma and...

June 16, 2020 06:57 PM AEST | By Team Kalkine Media

The healthcare sector is a significant and complex sector comprising a variety of companies engaged in manufacturing, developing, and selling of medic...

Don’t Miss! Small-Cap Healthcare Players’ Continued Focus on Innovat...

June 12, 2020 02:49 PM AEST | By Team Kalkine Media

In the healthcare world, the general trend has been that smaller biotech players work on the innovation angle with research and development activities...

3 Small-cap Healthcare Stocks to Watch Out For – IMM, IDX, AT1

June 11, 2020 02:53 PM AEST | By Team Kalkine Media

Small-cap stocks are listed companies with market capitalisation varying from USD 300 million to USD 2 billion or less. And in these stocks, there are...

Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASC...

June 03, 2020 11:42 AM AEST | By Team Kalkine Media

Summary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at AS...

Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2...

April 17, 2020 01:14 PM AEST | By Team Kalkine Media

Australian based clinical-stage Oncology company Prescient Therapeutics Limited (ASX:PTX), recently reported operating highlights and financial outcom...

Lens over SUDA’s Operational Highlights in 1H FY20

March 04, 2020 01:59 PM AEDT | By Hina Chowdhary

Continuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA Pharmaceuticals Ltd (ASX:SUD) has recently declar...

A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx

January 15, 2020 04:50 PM AEDT | By Hina Chowdhary

It’s surely a prosperous new year for the clinical-stage immuno-oncology player, Imugene Limited (ASX:IMU) that has received core US patent in t...

Prescient Collaborates with Carina Biotech in Expansion into Excitin...

December 10, 2019 04:19 PM AEDT | By Team Kalkine Media

Prescient Therapeutics Limited (ASX: PTX) develops personalised medicine approaches to address mutations that cause cancer. The Company employs a targ...

Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics

November 25, 2019 06:06 PM AEDT | By Team Kalkine Media

Health care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology....

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Mark...

August 20, 2019 04:36 PM AEST | By Team Kalkine Media

Imugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to ena...

Journey of Prescient Therapeutics in 2019

July 25, 2019 12:38 PM AEST | By Team Kalkine Media

Prescient Therapeutics Limited (ASX: PTX) is a clinical-stage oncology company that works on mutation causing cancer. The existing product portfolio o...

Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ D...

July 24, 2019 04:54 PM AEST | By Team Kalkine Media

Noxopharm Limited (ASX: NOX) has released July 2019 edition of its Newsletter called 'Versatility'. The clinical-stage drug development company, Noxo...

5 ASX Companies Leveraging AI to Drive Growth in 2024

Markets